Correlation Between Diameter and Occlusion Rate of Great Saphenous Vein on Revised Venous Clinical Severity Score after Endovenous Laser Ablation in Chronic Venous Insufficiency Patients
Annals of Vascular Surgery · 2025
DOI: 10.1016/j.avsg.2025.03.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Vascular Surgery, 2025. Verfasst von Raden Suhartono und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jaka…. Hauptthemen laut MEDLINE: Saphenous Vein, Venous Insufficiency, Laser Therapy, Endovascular Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Universitas Indonesia.
Abstract (Originalsprache)
BACKGROUND: The effectiveness of endovenous laser ablation (EVLA) on the diameter of the large saphenous vein is still widely debated, as the larger diameter of the saphenous vein has a lower occlusion rate after EVLA and can affect the Revised Venous Clinical Severity Score (r-VCSS) value. This study aims to determine the relationship between the diameter and occlusion rate of the great saphenous vein (GSV) post-EVLA. METHODS: This study was a cross-sectional design of patients with chronic venous insufficiency in the GSV who underwent EVLA. Thirty-seven extremities from 34 patients underwent a 1,470-nm EVLA with a radial tip. The diameter of the GSV was measured using Doppler ultrasound in 4 segments (3 femoral, 1 cruris), and pre-EVLA r-VCSS was also assessed. One week after EVLA, GSV occlusion was assessed using Doppler ultrasound and r-VCSS values. RESULTS: Per observations, 13.5% of cases failed occlusion 1 week post-EVLA. All occlusion failures occurred at the one-third proximal of the femoral segment (diameter >10 mm) (P < 0.05). There was no significant difference between occlusion rates with r-VCSS, comparing pre-EVLA and post-EVLA (P = 0.490 and P = 0.102). The difference in diameter according to the cut value does not affect the r-VCSS after the procedure. CONCLUSION: Pre-EVLA vein diameter influences the success of post-EVLA occlusion. The degree of GSV occlusion does not affect the r-VCSS after EVLA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, Department of Surgery, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Electronic address: raden.suhartono@yahoo.com.
- Division of Vascular and Endovascular Surgery, Department of Surgery, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
- Department of Community Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
- Department of Surgery, Faculty of Medicine, Hasanuddin University - Hasanuddin University Hospital, Makassar, Indonesia.
Förderung
- Universitas Indonesia
Zitieren
APA
Suhartono, R., Rinaldi, I., Vidiawati Sanyoto, D., Adriani, J. R., & Faruk, M. (2025). Correlation Between Diameter and Occlusion Rate of Great Saphenous Vein on Revised Venous Clinical Severity Score after Endovenous Laser Ablation in Chronic Venous Insufficiency Patients. Annals of Vascular Surgery. https://doi.org/10.1016/j.avsg.2025.03.021
Vancouver
Suhartono R, Rinaldi I, Vidiawati Sanyoto D, Adriani JR, Faruk M. Correlation Between Diameter and Occlusion Rate of Great Saphenous Vein on Revised Venous Clinical Severity Score after Endovenous Laser Ablation in Chronic Venous Insufficiency Patients. Annals of Vascular Surgery. 2025. doi:10.1016/j.avsg.2025.03.021
BibTeX
@article{Suhartono2025,
author = {Suhartono, Raden and Rinaldi, Ivan and Vidiawati Sanyoto, Dhanasari and Adriani, Januar Rizky and Faruk, Muhammad},
title = {Correlation Between Diameter and Occlusion Rate of Great Saphenous Vein on Revised Venous Clinical Severity Score after Endovenous Laser Ablation in Chronic Venous Insufficiency Patients},
journal = {Annals of Vascular Surgery},
year = {2025},
doi = {10.1016/j.avsg.2025.03.021}
}
EUVIMED